Viewing Study NCT04036461


Ignite Creation Date: 2025-12-24 @ 12:47 PM
Ignite Modification Date: 2026-01-25 @ 7:55 AM
Study NCT ID: NCT04036461
Status: TERMINATED
Last Update Posted: 2024-08-30
First Post: 2019-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma
Sponsor: Celgene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None Relapsed and refractory View
None CC-99712 View
None BCMA View
None Antibody drug conjugate View
None BMS-986405 View